| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
thioredoxin reductase 1 | 0.529 | 0.692 | 1.6E-06 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
nucleotide binding oligomerization domain containing 1 | 0.541 | 0.769 | 2.5E-18 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2013 | 2013 | ||||||||
|
mannose binding lectin 2 | 0.390 | 0.846 | 2.7E-03 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2008 | 2008 | ||||||||
|
vitamin D receptor | 0.352 | 0.885 | 1.7E-05 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2003 | 2003 | ||||||||
|
C-X3-C motif chemokine ligand 1 | 0.478 | 0.808 | 0.61 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2014 | 2014 | ||||||||
|
hydroxysteroid 17-beta dehydrogenase 6 | 0.592 | 0.692 | 0.35 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
major histocompatibility complex, class II, DR beta 3 | 0.570 | 0.885 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 1992 | 1992 | |||||||||
|
chymotrypsinogen B1 | 0.760 | 0.385 | 2.4E-06 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2013 | 2013 | ||||||||
|
sclerostin | 0.474 | 0.808 | 0.87 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
mannose-binding lectin family member 3, pseudogene | 0.518 | 0.769 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2008 | 2008 | |||||||||
|
major histocompatibility complex, class II, DP alpha 1 | 0.552 | 0.846 | 2.5E-06 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 1992 | 1992 | ||||||||
|
carbohydrate sulfotransferase 3 | 0.517 | 0.846 | 7.2E-03 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2013 | 2013 | ||||||||
|
poly(ADP-ribose) polymerase 1 | 0.389 | 0.923 | 3.3E-04 |
|
disease | 0.020 | None | 0.500 | 2 | 1 | 2009 | 2009 | ||||||||
|
major histocompatibility complex, class II, DP beta 1 | 0.453 | 0.923 | 5.3E-10 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 1992 | 1996 | ||||||||
|
crystallin gamma D | 0.510 | 0.808 | 3.0E-04 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2008 | 2014 | ||||||||
|
glucagon | 0.431 | 0.885 | 3.5E-02 |
|
disease | 0.050 | None | 0.800 | 5 | 0 | 2013 | 2018 | ||||||||
|
thyroid peroxidase | 0.455 | 0.846 | 1.8E-21 |
|
disease | 0.060 | None | 0.833 | 6 | 0 | 2017 | 2020 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.100 | None | 0.909 | 11 | 0 | 1992 | 2016 | ||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
disease | 0.100 | None | 0.923 | 13 | 0 | 1984 | 2013 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.400 | None | 1.000 | 31 | 0 | 1999 | 2020 | ||||||||
|
retinoic acid receptor alpha | 0.470 | 0.846 | 0.96 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 1994 | 2019 | ||||||||
|
metaxin 1 | 0.546 | 0.731 | 1.3E-02 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2011 | 2020 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2008 | 2020 | ||||||||
|
splicing factor 3b subunit 1 | 0.511 | 0.731 | 1.00 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2012 | 2019 | ||||||||
|
C-reactive protein | 0.299 | 0.962 | 3.7E-03 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1992 | 2019 |